Get startedLog in
    Picture of COSCIENS Biopharma logo

    CSCI — COSCIENS Biopharma News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Aeterna Provides Update On Pre-Clinical Results From AIM Biologicals Development Program

    Picture of COSCIENS Biopharma logoCOSCIENS Biopharma
    12/05/2022 13:08
    May 12 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS INC - UPDATE ON POSITIVE PRE-CLINICAL
RESULTS
FROM AIM BIOLOGICALS DEVELOPMENT PROGRAM FOR POTENTIAL TREATMENT
OF PARKINSON'S DISEASE
    * AETERNA ZENTARIS - ADVANCING DEVELOPMENT OF ITS AIM
BIOLOGICALS
AS A POTENTIAL THERAPEUTIC TREATMENT OPTION FOR PARKINSON'S
DISEASE

Source text for Eikon:  ID:nGNX7GQvXM 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on COSCIENS Biopharma

    See all news